Your browser doesn't support javascript.
loading
Thymoma followed by aplastic anemia: two different responses to immunosuppressive therapy
Castro, Murilo Antunes de; Castro, Mariana Antunes de; Arantes, Adriano de Moraes; Roberti, Maria do Rosário Ferraz.
Afiliación
  • Castro, Murilo Antunes de; Universidade Federal de Goiás. Faculdade de Medicina. Goiânia. BR
  • Castro, Mariana Antunes de; Universidade Federal de Goiás. Faculdade de Medicina. Goiânia. BR
  • Arantes, Adriano de Moraes; Universidade Federal de Goiás. Internal Medicine Department. Goiânia. BR
  • Roberti, Maria do Rosário Ferraz; Universidade Federal de Goiás. Internal Medicine Department. Goiânia. BR
Rev. bras. hematol. hemoter ; Rev. bras. hematol. hemoter;33(6): 476-477, Dec. 2011. tab
Article en En | LILACS | ID: lil-611386
Biblioteca responsable: BR408.1
ABSTRACT
Aplastic anemia is an uncommon complication of thymoma and is extremely infrequent after the surgical removal of a thymic tumor. Aplastic anemia is a result of marrow failure and is characterized by peripheral pancytopenia and severely depressed marrow cellularity; it may be an autoimmune manifestation of thymoma. As thymoma-associated hematological dyscrasias, which include pure red cell aplasia, aplastic anemia and myasthenia gravis, are supposed to be of immunologic origin, two cases of very severe aplastic anemia following the resection of lymphocytic thymomas treated with immunosuppression are herein presented.
Asunto(s)
Palabras clave

Texto completo: 1 Índice: LILACS Asunto principal: Ciclosporina / Tolerancia Inmunológica / Anemia Aplásica / Miastenia Gravis Límite: Aged / Humans / Male Idioma: En Revista: Rev. bras. hematol. hemoter Asunto de la revista: HEMATOLOGIA Año: 2011 Tipo del documento: Article

Texto completo: 1 Índice: LILACS Asunto principal: Ciclosporina / Tolerancia Inmunológica / Anemia Aplásica / Miastenia Gravis Límite: Aged / Humans / Male Idioma: En Revista: Rev. bras. hematol. hemoter Asunto de la revista: HEMATOLOGIA Año: 2011 Tipo del documento: Article